1242P Characteristics of the first 615 patients enrolled in Pacific R: A study of the first real-world data on unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy

Autor:	Ben Markman, H. Bouchaab, John K. Field, A. Sibille, Alyssa B Klein, I. Diaz Perez, Nicolas Girard, Muriel Licour, W. Sawyer, Daniel C. Christoph, Christian Schumann, M. Moskovitz, H.J.M. Smit, Marina Chiara Garassino, R. Fietkau, Vanesa Gregorc, Solange Peters, Maurice Pérol, Patrick Merle, Pilar Garrido
Rok vydání:	2020
Předmět:	Oncology medicine.medical_specialty Durvalumab business.industry Internal medicine medicine Stage III NSCLC Hematology business Real world data Chemoradiotherapy
Zdroj:	Annals of Oncology. 31:S805-S806
ISSN:	0923-7534
DOI:	10.1016/j.annonc.2020.08.115
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::9b1dcd502d5924361e3ff2f3d900d1cd https://doi.org/10.1016/j.annonc.2020.08.115 Zobrazit plný text záznamu